Company intelligence / Profile preview

Biotrace International

Bridgend, Wales, United Kingdom

Ownership: Private
Development stage: Other

Overview

Biotrace International was a leading developer and manufacturer of rapid microbiological testing systems used in food safety, healthcare, and industrial applications. The company specialized in ATP bioluminescence technology, which allows for the immediate detection of biological contamination on surfaces and in water. Its flagship product lines, such as Clean-Trace and Aqua-Trace, became industry standards for hygiene monitoring and quality control. In 2006, the company was acquired by 3M for approximately $460 million to strengthen its food safety and microbiology business.

Therapeutic areas: Infectious Diseases
Modalities: Device
Industry: Metabolite Diagnostics

Beyond the preview

Go deeper on Biotrace International.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Biotrace International.

Explore the full profile